Lifecore Biomedical, Inc. (LFCR): EPS (Diluted)
-$1.27
Year ended 2025-05-25
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-05-25 | -$1.27 | n/m | 2025-08-07, From 2024-05-27 |
| 2024-05-26 | $0.33 | n/m | 2025-08-07, From 2023-05-29 |
| 2023-05-28 | -$3.32 | n/m | 2024-08-26, From 2022-05-30 |
| 2022-05-29 | -$3.97 | n/m | 2024-08-26, From 2021-05-31 |
| 2021-05-30 | -$1.10 | n/c | 2024-03-20, From 2020-06-01 |
| 2020-05-31 | -$1.31 | n/m | 2023-03-16, From 2019-05-27 |
| 2019-05-26 | $0.01 | -98.9% | 2021-07-29, From 2018-05-28 |
| 2018-05-27 | $0.89 | +134.2% | 2020-08-14, From 2017-05-29 |
| 2017-05-28 | $0.38 | n/m | 2019-08-01, From 2016-05-30 |
| 2016-05-29 | -$0.43 | n/m | 2018-08-09, From 2015-06-01 |
| 2015-05-31 | $0.50 | -29.6% | 2018-03-15, From 2014-05-26 |
| 2014-05-25 | $0.71 | -16.5% | 2016-08-01, From 2013-05-27 |
| 2013-05-26 | $0.85 | +73.5% | 2015-07-31, From 2012-05-28 |
| 2012-05-27 | $0.49 | +226.7% | 2014-08-01, From 2011-05-30 |
| 2011-05-29 | $0.15 | 0.0% | 2013-08-07, From 2010-05-31 |
| 2010-05-30 | $0.15 | n/a | 2012-08-08, From 2009-06-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | -$1.27 | n/m |
| Xencor Inc (XNCR) | 2025-12-31 | -$1.24 | n/m |
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | $0.02 | -60.0% |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | -$17.93 | n/m |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $0.03 | n/a |
| Macrogenics Inc (MGNX) | 2025-12-31 | -$1.18 | n/m |
| Theravance Biopharma, Inc. (TBPH) | 2025-12-31 | $2.06 | n/m |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | -$0.12 | n/m |
| Zevra Therapeutics, Inc. (ZVRA) | 2025-12-31 | $1.35 | n/m |
Compare LFCR, XNCR, GYRE, KPTI side by side · Screen every company in Pharmaceutical Preparations ↗